Fig. 5.

Ratios of metabolic syndrome and depression/anxiety rates in patients with vs without PsA during follow-up. Follow-up ended on earliest occurrence of end of data, disenrollment, death or end of 5-year follow-up period. Values are reported by annual time interval during follow-up. Ratios of rates of claims (events/person-year) for metabolic syndrome, depression, and anxiety in patients in the PSO-PsA group during follow-up compared with patients in the PSO-only group are shown. Comorbidity events were defined as the occurrence of medical services or EHR diagnoses based on ICD-9-CM or ICD-10-CM codes. All events were counted for each comorbidity, including repeat events within patients. EHR electronic health record, ICD-9-CM/ICD-10-CM International Classification of Disease, 9th/10th Revision, Clinical Modification; PsA psoriatic arthritis, PSO psoriasis